Ting-Ting Chang | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Ting-Ting Chang l Medicine and Dentistry l Best Researcher Award

Associate Professor at National Yang Ming Chiao Tung University, Taiwan

Dr. Ting-Ting Chang is an Associate Professor at National Yang Ming Chiao Tung University, specializing in vascular medicine, kidney disease, diabetes, and new drug development. With a Ph.D. from National Yang-Ming University, Dr. Chang has a robust publication record in high-impact journals, including Science Translational Medicine and Angiogenesis. Recognized with awards such as the Young Scientists Award and the Young Investigator Fellowship, Dr. Chang is also a full member of Sigma Xi and other prestigious societies. Their research is notable for its innovation and significant contributions to understanding and treating complex diseases.

Profile:

Education

Ting-Ting Chang, Ph.D., earned her Ph.D. in Pharmacology from National Yang-Ming University in Taipei, Taiwan, in 2015. Her educational journey is distinguished by her continued academic and research excellence, which laid a strong foundation for her current role as an Associate Professor in the Department and Institute of Pharmacology at National Yang Ming Chiao Tung University. Prior to this, Dr. Chang completed her post-doctoral research at the same institution, further solidifying her expertise in pharmacology and related fields.

Professional Experience

Ting-Ting Chang, Ph.D., is an accomplished researcher and academic with extensive experience in the field of pharmacology. Currently serving as an Associate Professor at the Department and Institute of Pharmacology, National Yang Ming Chiao Tung University, Dr. Chang has previously held roles as an Assistant Professor and Post-doctoral Researcher at the same institution. Their career spans significant contributions to vascular medicine, kidney disease, diabetes, and new drug development, with a track record of high-impact research and numerous publications in leading scientific journals.

Research Interest

Ting-Ting Chang’s research interests encompass a broad range of topics within vascular medicine and molecular biology, focusing on the mechanisms underlying vascular dysfunction, kidney disease, and diabetes mellitus. Her work includes experimental animal model design and new drug development, aiming to uncover novel therapeutic targets and strategies for these critical health issues. Dr. Chang’s research integrates molecular and cellular approaches to address complex pathological conditions, contributing significantly to advancements in understanding and treating vascular and metabolic disorders.

Research Skills

Ting-Ting Chang, Ph.D., demonstrates exceptional research skills through a robust portfolio of high-impact publications and significant contributions to fields such as vascular medicine, kidney disease, and diabetes. With a strong academic background and extensive experience as both an Associate Professor and Post-doctoral Researcher, Dr. Chang excels in designing and conducting innovative studies, particularly in identifying novel therapeutic targets and mechanisms. Their proficiency in experimental animal model design and new drug development further highlights their expertise, while their membership in prestigious scientific societies and receipt of notable awards underscore their recognition and influence in the research community.

Award and Recognition

Ting-Ting Chang, Ph.D., has garnered significant awards and recognition throughout their career, underscoring their outstanding contributions to research. Notably, Dr. Chang received the Young Scientists Award at the 55th Annual Scientific Meeting of the Japan Atherosclerosis Society in 2023 and the Young Investigator Fellowship Award at the 88th European Atherosclerosis Society Congress in 2020. In addition, Dr. Chang was awarded full membership of Sigma Xi in 2023, reflecting their esteemed position in the scientific community and their impactful research in vascular medicine, kidney disease, and diabetes.

Conclusion

Ting-Ting Chang, Ph.D., is a highly qualified candidate for the Best Researcher Award. Their exceptional contributions to vascular medicine, kidney disease, and diabetes, along with a strong publication record and recognition in the scientific community, underscore their suitability for this award. Addressing areas for improvement, such as expanding research applications and increasing public engagement, could further enhance their profile as a leading researcher. Overall, Dr. Chang’s dedication, innovative research, and professional achievements make them an excellent contender for the Best Researcher Award.

Publication Top Notes

  • Association between vitiligo and risk of retinal detachment: a population-based cohort study in Taiwan
    • Authors: Chen, C.-L., Wu, C.-Y., Chen, Y.-L., Chang, Y.-T., Wu, C.-Y.
    • Year: 2024
    • Citations: 0
  • Rejuvenation of the dorsal hand by injectable poly-D, L-lactic acid: A pilot study
    • Authors: Ma, S.-H., Lin, C.-Y., Lin, J.-Y., Chang, Y.-T., Chen, C.-C.
    • Year: 2024
    • Citations: 0
  • Correlation of Disease Severity, Proinflammatory Cytokines, and Reduced Brain Gray Matter Volumes in Patients with Atopic Dermatitis
    • Authors: Li, C.-Y., Chang, W.-C., Chen, M.-H., Chen, Y.-Y., Bai, Y.-M.
    • Year: 2024
    • Citations: 0
  • Risk of Type 1 Diabetes Mellitus in Patients with Atopic Dermatitis: A Nationwide Population-Based Cohort Study
    • Authors: Li, M.-C., Wu, C.-Y., Chang, Y.-T., Lyu, Y.-S., Wu, C.-Y.
    • Year: 2023
    • Citations: 0
  • Assoziation zwischen chronischer Nierenerkrankung und dem Risiko für bullöses Pemphigoid: eine nationale bevölkerungsbasierte Kohortenstudie
    • Authors: Yu, W.-T., Ma, S.-H., Wu, C.-Y., Chang, Y.-T., Wu, C.-Y.
    • Year: 2023
    • Citations: 1

Sanja Stuhldreier | Social Media Marketing Communication | Best Researcher Award

Posted on by ScienceFather

Ms. Sanja Stuhldreier | Social Media Marketing Communication | Best Researcher Award

Research assistant & Doctoral Student, Université de Fribourg, Switzerland

Ms. Sanja Stuhldreier, a PhD candidate in Marketing at Université de Fribourg, Switzerland, stands out for her innovative research in customer-oriented marketing and corporate communication on social networks. Her academic journey includes a Master’s in Marketing and Sales from Université de Haute-Alsace and Hochschule Niederrhein, and a Bachelor’s in International Business Studies from Universität Paderborn, complemented by international research experience at Harvard University. Since October 2020, she has served as a full-time faculty member at Université de Fribourg, where she teaches “Data Analysis with SPSS,” supervises student theses, and delivers presentations at international conferences. Her diverse professional background spans marketing project management, visual merchandising, and content creation. Ms. Stuhldreier is also multilingual, fluent in German, English, and French, and holds additional qualifications in psychology and university teaching. Her blend of academic prowess, practical experience, and commitment to education positions her as a formidable candidate for the Best Researcher Award.

Profile

ORCID Profile

Education

Ms. Sanja Stuhldreier’s educational background is distinguished by a strong focus on marketing and communication. She is currently pursuing a PhD in Marketing at Université de Fribourg, Switzerland, where her research centers on customer-oriented marketing and corporate communication on social networks. Her academic journey includes a Master’s degree in Marketing and Sales from Université de Haute-Alsace and Hochschule Niederrhein, which provided her with a solid foundation in marketing strategies and sales techniques. She also holds a Bachelor’s degree in International Business Studies from Universität Paderborn, equipping her with a broad understanding of global business practices. Additionally, Ms. Stuhldreier has participated in an international research project at Harvard University, further enriching her academic experience. Her diverse educational background is complemented by a Certificate in “Psychology: Social Processes and Work Environment” from FernUniversität Hagen and a Diploma of Advanced Studies in “University Teaching and Instructional Technologies,” enhancing her expertise in both psychological dynamics and innovative teaching methodologies.

Professional Experience

Ms. Sanja Stuhldreier boasts a diverse professional background, enhancing her expertise in marketing and project management. Since October 2020, she has served as a full-time faculty member at Université de Fribourg, where she teaches “Data Analysis with SPSS,” supervises student theses, and delivers presentations at international conferences. Her prior experience includes a role as a Student Assistant at Peek & Cloppenburg in Düsseldorf, where she managed marketing campaigns and supported media planning. Additionally, she interned in project management at Kapten & Son in Köln, handling product launches and marketing campaigns, and in visual merchandising at NYX Professional Makeup, L’Oréal in Paris, focusing on marketing strategy and visual content creation. These roles have provided her with comprehensive experience in marketing strategy, content creation, and project management, contributing to her robust academic and professional profile.

Additional Qualifications

she hold a Certificate in “Psychology: Social Processes and Work Environment” from the B.Sc. Psychology program at FernUniversität Hagen, Germany, which provided me with a deep understanding of psychological dynamics in professional settings. Additionally, she earned a Diploma of Advanced Studies in “University Teaching and Instructional Technologies,” equipping me with advanced skills in educational methodologies and technology integration for effective teaching.

Publications Top Notes

  1. Unlocking (re)purchase potential through corporate responsiveness on social networks: The role of perceived customer orientation
    • Authors: Sanja Maria Stuhldreier
    • Year: 2024
  2. How does the corporate response rate to random consumer comments affect (re)purchase intentions of social network users? The role of perceived customer orientation
    • Authors: Sanja Maria Stuhldreier
    • Year: 2024
  3. Social media marketing communication: Do purchase intentions depend on corporate response strategies? The role of perceived response appropriateness
    • Authors: Sanja Maria Stuhldreier
    • Year: 2024
  4. Effects of corporate response patterns on social networks on brand attitudes and purchase intentions of observing consumers
    • Authors: Sanja Maria Stuhldreier
    • Year: 2023
  5. Effects of complaint management strategies on social networks on observers’ emotional attachment and brand commitment
    • Authors: Sanja Maria Stuhldreier
    • Year: 2022

 

 

Shichang Liu | Surgical nursing | Health Innovator’s Leadership Award

Posted on by ScienceFather

Mrs. Shichang Liu | Surgical nursing | Health Innovator’s Leadership Award

Nurse at The First People’s Hospital, China

Shichang Liu, a Nurse-in-Charge at Hangzhou First People’s Hospital affiliated with Westlake University, has over 15 years of specialized experience in plastic surgery nursing, particularly in hair transplantation. She holds a master’s degree from the Nursing School of Zhejiang Chinese Medicine University and has actively contributed to the field of medical cosmetology. Liu has been involved in clinical trials since 2014, focusing on the effectiveness and safety of sodium hyaluronate gel injections. Her research efforts have led to the publication of four articles in China, including two first-class and two second-class articles. Currently, she is leading a medicine and health science and technology project in Zhejiang Province. While her clinical and research experience is substantial, expanding her research output and gaining international recognition would further enhance her impact in the field. Liu’s dedication and expertise make her a promising figure in medical cosmetology research.

Education

Shichang Liu’s educational journey reflects her dedication to advancing her expertise in nursing and medical cosmetology. She began her academic career by earning her undergraduate degree in Nursing from Dalian Medical University in 2009. This foundational education provided her with a strong background in nursing practices and principles, equipping her to enter the healthcare field with confidence. Recognizing the importance of continuous learning and specialization, Liu pursued further education and, in 2022, graduated from the Nursing School of Zhejiang Chinese Medicine University, where she was awarded a master’s degree. Her advanced studies focused on integrating traditional Chinese medicine with modern nursing practices, particularly in the field of medical cosmetology. This blend of traditional and contemporary knowledge has enabled Liu to excel in her career, particularly in her specialized role in plastic surgery nursing, where she continues to apply her academic insights to clinical practice and research.

Professional Experience

Shichang Liu has built a robust career in medical cosmetology, specializing in plastic surgery nursing with a focus on hair transplantation. Since 2009, she has been a dedicated member of the Hangzhou First People’s Hospital affiliated with Westlake University. Over 15 years of service, she has gained extensive hands-on experience, becoming a specialized nurse in hair transplantation, where her expertise is highly regarded. Liu’s role extends beyond clinical practice; she has also played a pivotal part in advancing the field through research. As a research nurse since 2014, she has contributed to several clinical trials assessing the effectiveness and safety of sodium hyaluronate gel injections for wrinkle and facial contour modifications. Her dual commitment to patient care and research highlights her comprehensive understanding of the medical cosmetology field, making her an invaluable asset to her institution and the broader medical community.

Research Interest

Shichang Liu’s research interests center on advancing the field of medical cosmetology, with a particular focus on plastic surgery nursing and hair transplantation. Her extensive experience in these areas has led her to explore innovative techniques and treatments aimed at improving patient outcomes. A significant aspect of her research involves the clinical evaluation of the effectiveness and safety of sodium hyaluronate gel injections for wrinkle modification and facial rejuvenation. Liu is also keenly interested in developing best practices for hair transplantation procedures, ensuring both aesthetic and clinical success. Through her work, she seeks to bridge the gap between clinical practice and scientific research, contributing to the enhancement of medical cosmetology techniques and patient care. Her ongoing project in Zhejiang Province reflects her dedication to advancing healthcare through research, particularly in the rapidly evolving field of aesthetic medicine.

Research Skills

Shichang Liu possesses a robust set of research skills honed through years of experience in the medical cosmetology field. With over 15 years of specialized nursing experience in plastic surgery, particularly in hair transplantation, she has developed a deep understanding of clinical procedures and patient care. Her role as a research nurse since 2014 has equipped her with expertise in conducting clinical trials, specifically focusing on the effectiveness and safety of sodium hyaluronate gel injections for wrinkle and facial contour modifications. Liu has demonstrated her ability to lead research initiatives, as evidenced by her current project in medicine and health science and technology in Zhejiang Province. Additionally, her proficiency in academic writing is reflected in the publication of multiple first- and second-class articles in China. Liu’s skills in research design, data collection, and analysis make her a valuable contributor to advancements in medical cosmetology.

Award and Recognition

Shichang Liu, a Nurse-in-Charge at Hangzhou First People’s Hospital affiliated with Westlake University, is a distinguished professional in the field of medical cosmetology with over 15 years of specialized experience in plastic surgery nursing, particularly in hair transplantation. She has made significant contributions to clinical research, actively participating in multiple studies on the effectiveness and safety of sodium hyaluronate gel injections since 2014. Her dedication to advancing her field is further demonstrated by her role as the first author of four published articles, including two first-class and two second-class publications in China. Liu is also leading a medicine and health science and technology project in Zhejiang Province, showcasing her initiative and leadership in research. Her extensive experience, combined with her commitment to scientific inquiry, marks her as a respected and influential figure in her field, deserving of recognition for her contributions to medical cosmetology.

Conclusion

Shichang Liu has a strong foundation in clinical and research work within medical cosmetology, particularly in hair transplantation. Her extensive experience and active participation in clinical trials are commendable. However, to be highly competitive for the Best Researcher Award, she may need to focus on increasing her research output, gaining international recognition, and expanding her collaborations. Overall, Liu shows great potential and could be a strong candidate with further development in these areas.

 

 

 

Fatemeh Kazemi-Lomedasht | Medical Biotechnology | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Fatemeh Kazemi-Lomedasht | Medical Biotechnology | Best Researcher Award

Researcher of Pasteur Institute of Iran, Iran.

Fatemeh Kazemi-Lomedasht is an accomplished Associate Professor at the Biotechnology Research Center, Pasteur Institute of Iran. She holds a Ph.D. in Medical Biotechnology from Pasteur Institute and an M.Sc. in the same field from Tabriz University of Medical Sciences. Her research focuses on cancer biology, monoclonal antibodies, and drug delivery systems, particularly in developing nanobodies and targeted cancer therapies. She has authored numerous high-impact publications in journals such as TOXICON and Current Pharmaceutical Biotechnology. Her work includes innovative studies on nanobody development and targeted therapeutic strategies. Fatemeh is an active member of the American Chemical Society, Health Biotechnology Society, and Biotechnology Society, reflecting her engagement with the scientific community. Her contributions have advanced the field of biotechnology, and she continues to lead research efforts aimed at improving therapeutic and diagnostic applications.

Profile
Education

Fatemeh Kazemi-Lomedasht pursued her education in medical biotechnology with distinction. She completed her Ph.D. at the Pasteur Institute of Iran in 2015, where her dissertation focused on generating and selecting single-domain monoclonal antibodies (nanobodies) against vascular endothelial growth factor (VEGF) using phage display technology. This work contributed significantly to the field of targeted cancer therapies. Prior to her doctoral studies, she earned her M.Sc. in Medical Biotechnology from Tabriz University of Medical Sciences in 2011. Her master’s thesis investigated the anticancer properties of diferuloyl methane-containing nanoparticles and their effect on human telomerase reverse transcriptase gene expression in breast cancer cell lines. Both her Ph.D. and M.Sc. studies provided her with a strong foundation in molecular techniques, cancer research, and drug development, establishing her as a prominent researcher in her field.

Professional Experience

Fatemeh Kazemi-Lomedasht has had a distinguished career in the field of biotechnology. She has served as an Associate Professor at the Biotechnology Research Center of the Pasteur Institute of Iran since 2022, where she leads innovative research in cancer therapies, monoclonal antibodies, and drug delivery systems. Prior to this, she was an Assistant Professor at the same institution from 2015 to 2022, contributing significantly to the advancement of biotechnology research. During her tenure, she has been involved in groundbreaking studies on nanobodies and targeted cancer treatments, reflecting her expertise and leadership in the field. Her role includes overseeing research projects, mentoring junior researchers, and engaging with the scientific community. Fatemeh’s professional experience underscores her commitment to advancing biotechnological solutions and her influence in shaping research directions within her area of specialization

Research Interest

Fatemeh Kazemi-Lomedasht’s research interests are deeply rooted in advancing cancer research and biotechnology. Her work primarily focuses on the development and application of monoclonal antibodies and nanobodies for targeted cancer therapies, aiming to improve drug discovery and delivery methods. She is particularly interested in drug delivery systems that enhance the precision and efficacy of cancer treatments. Her research also delves into epitope mapping, which plays a crucial role in understanding protein interactions and designing targeted therapeutic agents. Kazemi-Lomedasht’s expertise extends to innovative approaches in developing functional nanobodies and evaluating their potential in combating various forms of cancer. Through her work, she seeks to contribute to the development of novel therapeutic strategies that can significantly impact cancer treatment and drug development, reflecting her commitment to advancing the field of biotechnology and improving patient outcomes.

Research Skills

Fatemeh Kazemi-Lomedasht possesses a comprehensive set of research skills crucial for advancing biotechnology. Her expertise encompasses a range of molecular techniques, including mammalian cell culture, isolation of primary cells, and cloning and expression of recombinant proteins. She is proficient in phage display technology, which has been pivotal in her work on generating and characterizing nanobodies. Additionally, Fatemeh is skilled in enzyme-linked immunosorbent assays (ELISA) and bioinformatics, which enhance her ability to analyze complex biological data. Her research frequently involves drug discovery and targeted delivery systems, reflecting her capability in designing and evaluating therapeutic agents. Her proficiency in these techniques, combined with her experience in epitope mapping and drug delivery research, highlights her ability to conduct high-impact research in the field of biotechnology and cancer therapeutics.

 Awards and Recognition

Fatemeh Kazemi-Lomedasht has garnered significant recognition for her contributions to the field of biotechnology. Her innovative research, particularly in monoclonal antibodies and drug discovery, has been well acknowledged in the scientific community. While specific awards are not listed, her impactful publications in high-profile journals such as TOXICON and Current Pharmaceutical Biotechnology highlight her contributions. Her work on nanobodies and targeted cancer therapies has been pivotal, reflecting her excellence in research. Additionally, her role as an Associate Professor at the Biotechnology Research Center of Pasteur Institute of Iran and her membership in prestigious scientific societies like the American Chemical Society, Health Biotechnology Society, and Biotechnology Society underscore her professional standing and influence. These achievements reflect her commitment to advancing biotechnology and her recognition as a leading researcher in her field.

Conclusion

Fatemeh Kazemi-Lomedasht is a highly qualified candidate for the Best Researcher Award, given her impressive research background, significant publications, and innovative contributions to biotechnology. Her strengths in cancer research and monoclonal antibodies are notable, and her role as an Associate Professor underscores her leadership in the field. Addressing areas for improvement, such as broadening the impact of her work and enhancing interdisciplinary collaboration, could further elevate her candidacy. Overall, her achievements and contributions make her a strong contender for this award.

Publications Top Notes

  • “Single-domain antibodies or nanobodies: a class of next-generation antibodies”
    • Authors: F Khodabakhsh, M Behdani, A Rami, F Kazemi-Lomedasht
    • Journal: International Reviews of Immunology
    • Year: 2018
    • Citations: 101
  • “Inhibition of angiogenesis in human endothelial cell using VEGF specific nanobody”
    • Authors: F Kazemi-Lomedasht, M Behdani, KP Bagheri, M Habibi-Anbouhi, …
    • Journal: Molecular Immunology
    • Year: 2015
    • Citations: 82
  • “Comparison of inhibitory effect of curcumin nanoparticles and free curcumin in human telomerase reverse transcriptase gene expression in breast cancer”
    • Authors: A Rami, N Zarghami
    • Journal: Advanced Pharmaceutical Bulletin
    • Year: 2013
    • Citations: 76
  • “Albumin nanoparticles as nanocarriers for drug delivery: Focusing on antibody and nanobody delivery and albumin-based drugs”
    • Authors: E Karami, M Behdani, F Kazemi-Lomedasht
    • Journal: Journal of Drug Delivery Science and Technology
    • Year: 2020
    • Citations: 74
  • “An overview on application of phage display technique in immunological studies”
    • Authors: A Rami, M Behdani, N Yardehnavi, M Habibi-Anbouhi, …
    • Journal: Asian Pacific Journal of Tropical Biomedicine
    • Year: 2017
    • Citations: 67
  • “The first report on transcriptome analysis of the venom gland of Iranian scorpion, Hemiscorpius lepturus”
    • Authors: F Kazemi-Lomedasht, V Khalaj, KP Bagheri, M Behdani, …
    • Journal: Toxicon
    • Year: 2017
    • Citations: 47
  • “Nanobodies as novel therapeutic agents in envenomation”
    • Authors: E Alirahimi, F Kazemi-Lomedasht, D Shahbazzadeh, M Habibi-Anbouhi, …
    • Journal: Biochemical and Biophysical Journal (BBA)-General Subjects
    • Year: 2018
    • Citations: 42
  • “Preparation and characterization of a novel nanobody against T-cell immunoglobulin and mucin-3 (TIM-3)”
    • Authors: V Homayouni, M Ganjalikhani-Hakemi, A Rezaei, H Khanahmad, …
    • Journal: Iranian Journal of Basic Medical Sciences
    • Year: 2016
    • Citations: 41
  • “Development of a mono‐specific anti‐VEGF bivalent nanobody with extended plasma half‐life for treatment of pathologic neovascularization”
    • Authors: A Sadeghi, M Behdani, S Muyldermans, M Habibi‐Anbouhi, …
    • Journal: Drug Testing and Analysis
    • Year: 2020
    • Citations: 33
  • “Design of a humanized anti vascular endothelial growth factor nanobody and evaluation of its in vitro function”
    • Authors: F Kazemi-Lomedasht, S Muyldermans, M Habibi-Anbouhi, M Behdani
    • Journal: Iranian Journal of Basic Medical Sciences
    • Year: 2018
    • Citations: 33